FDA D.I.S.C.O. Burst Edition: FDA approval of Keytruda (pembrolizumab) for patients with metastatic or locally advanced esophageal or gastroesophageal carcinoma
FDA D.I.S.C.O. Burst Edition: FDA approval of Keytruda (pembrolizumab) in combination with platinum and fluoropyrimidine-based chemotherapy for patients with metastatic or locally advanced esophageal or gastroesophageal carcinoma. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 9, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Esophageal Cancer: An Updated Review Esophageal Cancer: An Updated Review
The incidence of esophageal cancer is on the rise. Review its epidemiology, risk factors, diagnosis and management in this update.Southern Medical Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 5, 2021 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

Mayo Clinic Q & amp;A podcast: Esophageal cancer is one of the deadliest cancers
Esophageal cancer occurs in the esophagus -- a long, hollow tube that runs from the throat to the stomach -- and can occur anywhere along the esophagus. Men are more likely to develop esophageal cancer than women. While treatable, esophageal cancer is rarely curable. "It's an uncommon cancer," says Dr. Shanda Blackmon, a Mayo Clinic general thoracic surgeon. [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 5, 2021 Category: Databases & Libraries Source Type: news

Adjuvant Nivolumab Beneficial in Esophageal, GE Junction Cancer
Disease - free survival significantly longer in patients with resected esophageal, gastroesophageal junction cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 1, 2021 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Pharmacy, Journal, Source Type: news

Drug Could Be a ‘ Game - Changer ’ in Fighting Esophageal Cancers
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 1, 2021 Category: Cancer & Oncology Tags: Oncology, Pharmacy, News, Source Type: news

Adjuvant Nivolumab Beneficial in Esophageal, GE Junction Cancer
THURSDAY, April 1, 2021 -- Among patients with resected esophageal or gastroesophageal junction cancer who have received neoadjuvant chemoradiotherapy, disease-free survival is significantly longer with nivolumab adjuvant therapy versus placebo,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 1, 2021 Category: Pharmaceuticals Source Type: news

Drug Could Be a'Game-Changer' in Fighting Esophageal Cancers
THURSDAY, April 1, 2021 -- Patients who have surgery for esophageal cancer commonly see the disease return, but a drug that boosts the immune system may help delay or prevent that, a new trial has found. The drug, called Opdivo (nivolumab), doubled... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 1, 2021 Category: General Medicine Source Type: news

Drug Could Be a'Game-Changer' in Fighting Esophageal Cancers
Title: Drug Could Be a'Game-Changer'in Fighting Esophageal CancersCategory: Health NewsCreated: 4/1/2021 12:00:00 AMLast Editorial Review: 4/1/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 1, 2021 Category: Cancer & Oncology Source Type: news

Discontinuing chemotherapy for oesophageal cancer cost effective?
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2021 Category: Drugs & Pharmacology Source Type: news

A ‘Game Changer’ for Patients With Esophageal Cancer
A drug that unleashes the immune system offers a rare glimmer of hope for those with a cancer that resists most treatments. (Source: NYT Health)
Source: NYT Health - March 31, 2021 Category: Consumer Health News Authors: Gina Kolata Tags: Clinical Trials Esophageal Cancer Drugs (Pharmaceuticals) Chemotherapy Radiation Alcoholic Beverages Bristol Myers Squibb Company New England Journal of Medicine East Asia United States Source Type: news

Procedures identify Barrett's esophagus patients at risk for cancer progression
(Johns Hopkins Medicine) A combination of esophageal brushing and extensive genetic sequencing of the sample collected can detect chromosome alterations in people with Barrett's Esophagus, identifying patients at risk for progressing to esophageal cancer, according to a new study by researchers at the Johns Hopkins Kimmel Cancer Center and Case Western Reserve University. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 29, 2021 Category: International Medicine & Public Health Source Type: news

FDA Approves Merck ’s Keytruda (pembrolizumab) Plus Platinum- and Fluoropyrimidine-Based Chemotherapy for Treatment of Certain Patients With Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction (GEJ) Carcinoma
KENILWORTH, N.J.--(BUSINESS WIRE) March 23, 2021 -- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Keytruda, Merck’s anti-PD-1 therapy, for... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 23, 2021 Category: Drugs & Pharmacology Source Type: news

Electronic 'nose' that detects chemicals in breath may help spot early signs of oesophageal tumour 
The breathalyser-type device uses sensors to identify patterns of compounds found in breath that are unique to Barrett's oesophagus, a 'pre' condition to the cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - March 23, 2021 Category: Consumer Health News Source Type: news

FDA approves pembrolizumab for esophageal or GEJ carcinoma
FDA approved pembrolizumab (Keytruda, Merck Sharp& Dohme Corp.) in combination with platinum and fluoropyrimidine-based chemotherapy for patients with metastatic or locally advanced esophageal or gastroesophageal carcinoma who are not candidates for surgical resection or definitive chemoradiation. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 22, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

New Barrett's esophagus monitoring method could aid in easier and more precise prognoses
(Case Western Reserve University) Researchers find that a single esophageal brushing, combined with massively parallel sequencing, can identify Barrett's esophagus patients with disease progression to precancerous cells or carcinoma (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 22, 2021 Category: International Medicine & Public Health Source Type: news

Hospital becomes the first in the world to use a 'sponge on a string' to detect oesophageal cancer
University College London Hospital switched to the pioneering Cytosponge to assess patients after NHS bosses banned the use of endoscopies during the pandemic. (Source: the Mail online | Health)
Source: the Mail online | Health - March 17, 2021 Category: Consumer Health News Source Type: news

A new type of recyclable: Finding new uses for established drugs
(Tokyo Medical and Dental University) Using cell culture and mouse model approaches, researchers from Tokyo Medical and Dental University (TMDU) have found a novel drug combination that can inhibit tumor growth in oral and esophageal carcinomas. They also identified a potential biomarker that can help predict patient sensitivity to this treatment. These findings provide valuable knowledge for the fight against these deadly cancers and demonstrate a potential new use for drugs currently approved for other diseases. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 16, 2021 Category: Cancer & Oncology Source Type: news

Age Should Not Prevent Aggressive Esophageal Cancer Treatment Age Should Not Prevent Aggressive Esophageal Cancer Treatment
Neoadjuvant chemoradiation plus esophagectomy can be performed safely in well-selected older patients with locally advanced esophageal or esophagogastric junction cancer, according to a reviewMedscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 2, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Optimal Therapy for Esophageal Cancer Feasible in Fit Elderly
Those 70 years and older have similar postoperative complication scores and long - term survival (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 26, 2021 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Radiology, Surgery, Geriatrics, Journal, Source Type: news

Optimal Therapy for Esophageal Cancer Feasible in Fit Elderly
FRIDAY, Feb. 26, 2021 -- Patients 70 years and older with locally advanced esophageal or esophagogastric junction (EGJ) cancer should be considered for optimal, potentially curative therapy, including neoadjuvant chemoradiotherapy and surgical... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 26, 2021 Category: Pharmaceuticals Source Type: news

Chronic Heartburn Raises Odds for Cancers of Larynx, Esophagus
Title: Chronic Heartburn Raises Odds for Cancers of Larynx, EsophagusCategory: Health NewsCreated: 2/22/2021 12:00:00 AMLast Editorial Review: 2/23/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 23, 2021 Category: Cancer & Oncology Source Type: news

Chronic Heartburn Raises Odds for Cancers of Larynx, Esophagus
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 23, 2021 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, News, Source Type: news

Heartburn Raises Odds for Esophageal, Larynx Cancers
Researchers found that those with gastroesophageal reflux disease (GERD) had about twice the risk of developing cancers of the esophagus or larynx. (Source: WebMD Health)
Source: WebMD Health - February 22, 2021 Category: Consumer Health News Source Type: news

Chronic Heartburn Raises Odds for Cancers of Larynx, Esophagus
MONDAY, Feb. 22, 2021 -- People with chronic heartburn may face increased risks of several rare types of cancer, a large U.S. government study shows. Researchers found that among more than 490,000 Americans aged 50 and up, those with... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 22, 2021 Category: General Medicine Source Type: news

Chronic heartburn doubles risk for certain cancers, study finds
People with chronic heartburn may be twice as likely to develop throat and esophageal cancers than those without the condition, according to a study published Monday by the journal Cancer. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 22, 2021 Category: Consumer Health News Source Type: news

GERD Linked to Squamous Cell Cancers of Larynx, Esophagus
MONDAY, Feb. 22, 2021 -- Gastroesophageal reflux disease (GERD) appears to be associated with an increased risk for squamous cell cancers of the larynx and esophagus, according to a study published online Feb. 22 in Cancer. Shao-Ming Wang, Ph.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 22, 2021 Category: Pharmaceuticals Source Type: news

Acid reflux disease may increase risk of cancers of the larynx and esophagus
(Wiley) Results from a large prospective study indicate that gastroesophageal reflux disease (GERD), which also causes heartburn symptoms, is linked with higher risks of various cancers of the larynx (or voice box) and esophagus. The study is published early online in CANCER, a peer-reviewed journal of the American Cancer Society. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 22, 2021 Category: Cancer & Oncology Source Type: news

Elderly esophageal cancer patients often receive suboptimal therapy due to perceived risks
(American College of Surgeons) Elderly patients (70 years and over) with locally advanced esophageal (E) and esophagogastric junction (EGJ) cancer (located in the stomach and esophagus) should be considered for optimal therapy that has the potential to cure. This therapy regimen includes initial chemoradiotherapy (NACR) and surgical resection, an operation that removes the cancerous part of the organ. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 9, 2021 Category: Cancer & Oncology Source Type: news

Novel 3D printed stents deliver breakthrough treatment for oesophageal cancer
(University of South Australia) World-first 3D printed oesophageal stents developed by the University of South Australia could revolutionise the delivery of chemotherapy drugs to provide more accurate, effective and personalised treatment for patients with oesophageal cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 2, 2021 Category: International Medicine & Public Health Source Type: news

Higher Intensity Therapy and Surgical Risk in Esophageal Cancer Higher Intensity Therapy and Surgical Risk in Esophageal Cancer
Combining standard neoadjuvant chemotherapy for locally advanced esophageal cancer with either radiation or docetaxel did not increase the risk of surgical complications, investigators in the JCOG1109 trial reported.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 29, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Esophageal cancer patients show abundance of oral pathogens
(Tokyo Medical and Dental University) DNA from various oral bacterial pathogens has been found in tumors from esophageal cancer patients. Researchers led by Tokyo Medical and Dental University (TMDU) examined bacterial pathogens in plaque and saliva from esophageal cancer patients, determining that a prevalence of three species in particular, along with alcohol consumption, is associated with a high risk of esophageal cancer. Screening of oral pathogens could therefore be used for early disease detection. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 14, 2021 Category: Cancer & Oncology Source Type: news

CT helps radiologists plan facial feminization surgery
Using CT, radiologists can play a key role in planning facial feminization...Read more on AuntMinnie.comRelated Reading: CT radiomics predicts esophageal cancer outcomes The must-know for breast imaging in transgender patients AJR publishes primer on gender affirmation surgery Breast imaging centers lack inclusive transgender care Intraoperative CT fine-tunes maxillofacial surgery (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 7, 2021 Category: Radiology Source Type: news

Incidence of Young - Onset Esophageal Adenocarcinoma Rising
Young - onset esophageal adenocarcinoma presenting at more advanced stages; proportion of advanced stage up from 1975 to 2015 (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 28, 2020 Category: Cancer & Oncology Tags: Family Medicine, Gastroenterology, Internal Medicine, Oncology, Journal, Source Type: news

Incidence of Young-Onset Esophageal Adenocarcinoma Rising
MONDAY, Dec. 28, 2020 -- The incidence of young-onset esophageal adenocarcinoma is increasing, and patients present at more advanced stages compared with older patients, according to a study published online Dec. 11 in Cancer Epidemiology,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 28, 2020 Category: Pharmaceuticals Source Type: news

Esophageal Cancer on the Rise Among the Young: Study
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 22, 2020 Category: Cancer & Oncology Tags: Family Medicine, Oncology, Preventive Medicine, News, Source Type: news

Esophageal Cancer on the Rise Among the Young: Study
TUESDAY, Dec. 22, 2020 -- Esophageal cancer is increasing among young Americans, and they're more likely to be diagnosed with advanced disease, according to a new study. Esophageal cancer accounts for about 1% of U.S. cancer diagnoses, and just... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 22, 2020 Category: General Medicine Source Type: news

Esophageal Cancer on the Rise Among the Young: Study
Title: Esophageal Cancer on the Rise Among the Young: StudyCategory: Health NewsCreated: 12/22/2020 12:00:00 AMLast Editorial Review: 12/22/2020 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - December 22, 2020 Category: Cancer & Oncology Source Type: news

Esophageal Cancer Incidence Up in Young Adults
Esophageal Cancer Incidence Up in Adults Under Age 50 (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - December 22, 2020 Category: General Medicine Source Type: news

Esophageal Cancer Incidence Up in Adults Under Age 50 Esophageal Cancer Incidence Up in Adults Under Age 50
Researchers found that 84.9% of cases diagnosed in younger adults were at regional or distant stages. This compares with 77.6% and 67.8% of cases in those aged 50-69 and 70 and older, respectively.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - December 21, 2020 Category: Primary Care Tags: Hematology-Oncology News Source Type: news

Incidence of esophageal adenocarcinoma is increasing in younger adults
(American Association for Cancer Research) Esophageal adenocarcinoma is occurring more frequently in adults under age 50, and these younger adults are more likely to be diagnosed at advanced stages. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 16, 2020 Category: International Medicine & Public Health Source Type: news

Four-week cancer treatment delay raises death risk by 10% – study
Concern for NHS cancer patients after record numbers miss treatment due to pandemicCoronavirus – latest updatesSee all our coronavirus coverageDelaying cancer treatment by just four weeks increases the risk of death by up to 10%, according to new research that shows the devastating impact of missed NHS treatment targets due to Covid.Earlier this year, Dr Ajay Aggarwal at the London School of Hygiene and Tropical Medicine estimated that diagnostic delays caused by lockdown measures and changes to patient behaviour as a result of Covid-19 would result in3,500 avoidable deaths from breast, lung, oesophageal or bowel can...
Source: Guardian Unlimited Science - November 4, 2020 Category: Science Authors: Linda Geddes Science correspondent Tags: Cancer Health Society NHS Bowel cancer Breast cancer Coronavirus Infectious diseases Medical research Science UK news Source Type: news

Oesophageal cancer symptoms: Prolonged indigestion could be a sign of the deadly disease
OESOPHAGEAL cancer occurs when abnormal cells multiply uncontrollably in the food pipe . This is the passageway between the mouth to the stomach. Prolonged indigestion could be a sign of the deadly disease. (Source: Daily Express - Health)
Source: Daily Express - Health - November 4, 2020 Category: Consumer Health News Source Type: news

New 'sponge on a string' test can pick up early signs of oesophageal cancer
The one-minute procedure, which can be carried out by a GP or a nurse, involves swallowing a pill containing a sponge-like material attached to a piece of thread. (Source: the Mail online | Health)
Source: the Mail online | Health - October 24, 2020 Category: Consumer Health News Source Type: news

Icotinib Plus Radiotherapy Ups Survival in Elderly With Esophageal Cancer Icotinib Plus Radiotherapy Ups Survival in Elderly With Esophageal Cancer
Icotinib with concurrent radiotherapy (RT) boosts survival and may have other benefits compared to RT alone in elderly patients with unresectable esophageal squamous cell carcinoma, according to Chinese researchers.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - October 19, 2020 Category: Radiology Tags: Hematology-Oncology News Source Type: news

Oncotarget: Geriatric nutritional risk index - prognostic marker of esophageal carcinoma
(Impact Journals LLC) Oncotarget Volume 11, Issue 29 reported that In multivariate analyses, serum albumin, GNRI, pathological tumor-node-metastasis stage, and tumor differentiation were independent prognostic factors for CSS. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 16, 2020 Category: Cancer & Oncology Source Type: news

AI aids detection of metastasis on bone scintigraphy
An artificial intelligence (AI) model was able to help nuclear medicine physicians...Read more on AuntMinnie.comRelated Reading: AI algorithm detects COVID, flu, other pneumonia Screening saves lives of women with high-risk tumors AMVC Fall 2020: AI can reshape radiology post-COVID-19 CT radiomics predicts esophageal cancer outcomes What will be the killer apps for AI in MRI? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 14, 2020 Category: Radiology Source Type: news

Breakthrough in treatment of cancer which killed Inspector Morse star John Thaw
Actor John Thaw, star of ITV's long-running series Inspector Morse, survived just eight months after being diagnosed with oesophageal cancer. He died in 2002, aged 60. (Source: the Mail online | Health)
Source: the Mail online | Health - October 10, 2020 Category: Consumer Health News Source Type: news

New First-Line Standard of Care for Esophageal Cancer? New First-Line Standard of Care for Esophageal Cancer?
Pembrolizumab plus chemotherapy should be a new standard of care for first-line treatment, say researchers. Patients with squamous cell carcinomas and higher levels of PD-L1 benefited most.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 23, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Immunotherapy is beneficial in gastric and oesophageal cancers, studies show
(European Society for Medical Oncology) New data presented at ESMO 2020 have shown that immunotherapy is beneficial for patients with gastric and oesophageal cancers who currently have poor survival. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 21, 2020 Category: Cancer & Oncology Source Type: news

Chemoradiotherapy Raises Risk of Thoracic Vertebral Fracture Chemoradiotherapy Raises Risk of Thoracic Vertebral Fracture
Chemoradiotherapy for esophageal cancer increases the risk of thoracic vertebral fractures, researchers in Japan report.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - September 15, 2020 Category: Pathology Tags: Hematology-Oncology News Source Type: news